MAFEIP

MAFEIPMAFEIP is a web-based tool whose purpose is to estimate the health and economic outcomes of a large variety of social and technological innovations. From the EIP on AHA perspective, MAFEIP represents the key instrument to estimate the impact of EIP on AHA interventions.

 

Overall activities

MAFEIP enables early impact assessments of an innovative process in the health and care sector. Using this tool can help decision-makers to take informed decisions about the future design of this innovative process or about its deployment on a larger scale (this is the “decision to invest”).

MAFEIP can also help, at a later stage of the innovation development, to assess precisely its value for citizens and other stakeholders (this is the “decision to buy”).

The potential users of the MAFEIP tool are stakeholders in the health and care sectors who are willing to deploy innovative practices to improve quality of care, enhance accessibility or make more efficient use of resources. 

 

Progress so far

During the EIP on AHA Conference of Partners in 2019, a session entitled “Enabling implementation decisions. Assessing the effectiveness of AAL: the case of EvAALuation and MAFEIP (joint session AAL/EIP on AHA)” was dedicated to showcasing the new tool. It illustrated how it can support evidence-based decision making in health and social care intervention design. The session was co-chaired by the AIT Austrian Institute of Technology and led by Prof. Dr. Francisco Lupiáñez-Villanueva, Open Evidence Co-Founder and Director. The attendees learned from Prof. Lupiáñez-Villanueva what are the relevance and benefits of using MAFEIP.

Earlier, in June 2018, a call was launched to invite organisations to use MAFEIP, which led to it having 72 new members. The MAFEIP Users’ Community has been growing since February 2017, grouping together an increasing number of organisations across Europe.

The MAFEIP team is now holding multiple meetings with some of the interested organisations to help them use MAFEIP to evaluate their interventions. This activity is supported by the coordination and support action, WE4AHA

MAFEIP 2.0 has already been used to develop new use cases, the cost-effectiveness analysis of Do CHANGE, City4Age and Puglia. For information, visit the MAFEIP website.


What is next?

By autumn 2019, the MAFEIP community has 225 members from 27 countries (20 are within the EU). MAFEIP’s goal is to continue expanding the community throughout 2020 and finalise even more use cases.

/file/mafeip-users%E2%80%99-community-number-members-1_enThe MAFEIP Users’ Community. Number of members

A graph indicating the increase in MAFEIP users

The MAFEIP support team will continue to provide technical and operational support to all those organisations that wish to use MAFEIP to assess impact and cost-effectiveness of the digital health interventions they are implementing or planning to adopt.

The MAFEIP team is leveraging the breadth of the members’ existing international networks and the multiple connections established through European funded projects to promote the use of MAFEIP across Europe.

The MAFEIP support team at Open Evidence is committed to disseminate the work of the MAFEIP community. It will increase its outreach through different channels so as to expand engagement with and use of the MAFEIP tool.

Regular reports of MAFEIP outputs will be released, illustrating the impact on the EIP on AHA activities. 

The MAFEIP tool is open to any interested organisation or individual. So, if you are willing and interested to try the tool, do not hesitate to ask for a username at [email protected]